562 - CRISPR-Cas9-based target validation for p53-reactivating model compounds
| Autor: | Wanzel, M., Vischedyk, J., Gittler, M., Gremke, N., Mernberger, M., Charles, J., Schneikert, J., Bretz, A.C., Nist, A., Stiewe, T. |
|---|---|
| Zdroj: | In European Journal of Cancer July 2016 61 Supplement 1:S122-S122 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect